Richard N. Armstrong, Ph.D., professor of Biochemistry and Chemistry, prominent biochemist, journal editor and mentor, died on June 18 after a brief illness. He was 66.
A new imaging probe developed by Vanderbilt investigators enhances tumor visibility and has broad applications in diagnosing and monitoring patients with cancer.
Inhibitors of the enzyme phospholipase D1 suppress the replication of HIV-1, Vanderbilt investigators have discovered.
Vanderbilt and the Waters Centers of Innovation Program are sponsoring a free symposium titled “Integrated ‘Omics in Translational Medicine” on March 23. It is open to all scientists interested in the subject.
Drugs developed at Vanderbilt could provide a new way to treat schizophrenia in a personalized way.
Insights into the workings of DNA damage response proteins such as SMARCAL1 could suggest new ways to improve genome integrity and prevent cancer.
Accessibility Tools